Showing results (151-160 of 213) with videos related to

Sort By:
Pageof 22
JCI Insight|April 7, 2022
SARS-CoV-2-specific immune responses in boosted vaccine recipients with breakthrough infections during the Omicron variant surgeBezawit A Woldemeskel, Caroline C Garliss, Tihitina Y Aytenfisu, et al.
Future Virology|September 27, 2021
High-value laboratory testing for hospitalized COVID-19 patients: a reviewDaniela Cihakova, Michael B Streiff, Steven P Menez, et al.
Cell Chemical Biology|March 28, 2024
Multiparatopic antibodies induce targeted downregulation of programmed death-ligand 1Seth D Ludwig, Bunyarit Meksiriporn, Jiacheng Tan, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 1, 2019
Sex Discrepancies in the Protective Effect of Opioid Agonist Therapy on Incident Hepatitis C InfectionLouise Geddes, Jenny Iversen, Handan Wand, et al.
The Journal of Clinical Investigation|February 11, 2021
Durable SARS-CoV-2 B cell immunity after mild or severe diseaseClinton O Ogega, Nicole E Skinner, Paul W Blair, et al.
Journal of Hepatology|April 3, 2020
Antibody avidity-based approach to estimate population-level incidence of hepatitis CDenali Boon, Veronica Bruce, Eshan U Patel, et al.
JCI Insight|April 27, 2023
Heterologous versus homologous boosting elicits qualitatively distinct, BA.5-cross-reactive T cells in transplant recipientsElizabeth A Thompson, Wabathi Ngecu, Laila Stoddart, et al.
Plos One|April 4, 2015
Patterns of hepatitis C virus RNA levels during acute infection: the InC3 studyBehzad Hajarizadeh, Bart Grady, Kimberly Page, et al.
Science Translational Medicine|May 21, 2025
SARS-CoV-2 induces neutrophil degranulation and differentiation into myeloid-derived suppressor cells associated with severe COVID-19Leon L Hsieh, Elizabeth A Thompson, Nirvani P Jairam, et al.
Pageof 22